Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1

Circulation Research

Volumn 104, Issue 5, 2009, Pages 600-608

  Stefulj, Jasminka ^a,b   Panzenboeck, Ute ^a   Becker, Tatjana ^a   Hirschmugl, Birgit ^a   Schweinzer, Cornelia ^a   Lang, Ingrid ^a   Marsche, Gunther ^a   Sadjak, Anton ^a   Lang, Uwe ^a   Desoye, Gernot ^a   Wadsack, Christian ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Endothelial cells; Fetal cholesterol transfer; HDL; Liver X receptors; Maternal

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIVER X RECEPTOR; SCAVENGER RECEPTOR BI; ABC TRANSPORTER; ABCG1 PROTEIN, HUMAN; ABCG4 PROTEIN, HUMAN; CELL RECEPTOR; DNA BINDING PROTEIN; GLIBENCLAMIDE; HIGH DENSITY LIPOPROTEIN 3; PROBUCOL; SCARB1 PROTEIN, HUMAN; SCAVENGER RECEPTOR B; SMALL INTERFERING RNA;

APICAL MEMBRANE; ARTICLE; BLOOD PLACENTA BARRIER; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENDOTHELIUM CELL; FETOPLACENTAL UNIT; FETUS CIRCULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN; VASCULARIZATION; CELL CULTURE; CELL MEMBRANE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; FETOMATERNAL TRANSFUSION; GENETICS; METABOLISM; PLACENTA; PREGNANCY; RNA INTERFERENCE; TIME;

APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; CELL MEMBRANE; CELLS, CULTURED; CHOLESTEROL; DNA-BINDING PROTEINS; ENDOTHELIAL CELLS; FEMALE; GLYBURIDE; HUMANS; LIPOPROTEINS, HDL3; MATERNAL-FETAL EXCHANGE; PLACENTA; PREGNANCY; PROBUCOL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA INTERFERENCE; RNA, SMALL INTERFERING; SCAVENGER RECEPTORS, CLASS B; TIME FACTORS;

EID: 63649125490     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.108.185066     Document Type: Article

References (45)

1. Huang X, Litingtung Y, Chiang C. Region-specific requirement for cholesterol modification of sonic hedgehog in patterning the telencephalon and spinal cord. Development. 2007;134:2095-2105.
2. Woollett LA. Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation. Am J Clin Nutr. 2005;82:1155-1161.
3. Woollett LA. Where does fetal and embryonic cholesterol originate and what does it do? Annu Rev Nutr. 2008;28:97-114.
4. Witsch-Baumgartner M, Fitzky BU, Ogorelkova M, Kraft HG, Moebius FF, Glossmann H, Seedorf U, Gillessen-Kaesbach G, Hoffmann GF, Clayton P, Kelley RI, Utermann G. Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome. Am J Hum Genet. 2000;66:402-412.
5. Napoli C, D'Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, Palinski W. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997;100:2680-2690.
6. Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J. 2002;16:1348-1360.
7. Yamashita T, Freigang S, Eberle C, Pattison J, Gupta S, Napoli C, Palinski W. Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring. Circ Res. 2006;99: e51-e64.
8. Alsat E, Bouali Y, Goldstein S, Malassine A, Berthelier M, Mondon F, Cedard L. Low-density lipoprotein binding sites in the microvillous membranes of human placenta at different stages of gestation. Mol Cell Endocrinol. 1984;38:197-203. (Pubitemid 15191249)
9. Malassine A, Besse C, Roche A, Alsat E, Rebourcet R, Mondon F, Cedard L. Ultrastructural visualization of the internalization of low density lipoprotein by human placental cells. Histochemistry. 1987;87: 457-464.
10. Wadsack C, Hammer A, Levak-Frank S, Desoye G, Kozarsky KF, Hir-schmugl B, Sattler W, Malle E. Selective cholesteryl ester uptake from high density lipoprotein by human first trimester and term villous tro-phoblast cells. Placenta. 2003;24:131-143. (Pubitemid 37184708)
11. Xie X, Zhu Y. Insights into cholesterol efflux in vascular endothelial cells. Cardiovasc Hematol Disord Drug Targets. 2007;7:127-134.
12. Oram JF, Vaughan AM. ATP-binding cassette cholesterol transporters and cardiovascular disease. Circ Res. 2006;99:1031-1043.
13. Bansal N, Cruickshank JK, McElduff P, Durrington PN. Cord blood lipoproteins and prenatal influences. Curr Opin Lipidol. 2005;16: 400-408.
14. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res. 2005;96:1221-1232.
15. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet. 1999;22:347-351.
16. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, Seilhamer JJ, Vaughan AM, Oram JF. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest. 1999;104:R25-31.
17. Tall AR. Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J Intern Med. 2008;263:256-273.
18. Connelly MA, Williams DL. Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids. Curr Opin Lipidol. 2004;15:287-295.
19. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature. 1996;383:728-731.
20. Costet P, Luo Y, Wang N, Tall AR. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem. 2000;275:28240-28245.
21. Venkateswaran A, Laffitte BA, Joseph SB, Mak PA, Wilpitz DC, Edwards PA, Tontonoz P. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci U S A. 2000; 97:12097-12102.
22. Wang N, Lan D, Chen W, Matsuura F, Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high density lipoproteins. Proc Natl Acad Sci U S A. 2004;101:9774-9779.
23. Hassan HH, Denis M, Krimbou L, Marcil M, Genest J. Cellular cholesterol homeostasis in vascular endothelial cells. Can J Cardiol. 2006; 22(suppl B):35B-40B.
24. Kritharides L, Jessup W, Mander EL, Dean RT. Apolipoprotein A-I-mediated efflux of sterols from oxidized LDL-loaded macrophages. Arterioscler Thromb Vasc Biol. 1995;15:276-289.
25. Wang N, Silver DL, Thiele C, Tall AR. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem. 2001;276:23742-23747.
26. Favari E, Zanotti I, Zimetti F, Ronda N, Bernini F, Rothblat GH. Probucol inhibits ABCA1-mediated cellular lipid efflux. Arterioscler Thromb Vasc Biol. 2004;24:2345-2350.
27. Nieland TJ, Shaw JT, Jaipuri FA, Duffner JL, Koehler AN, Banakos S, Zannis VI, Kirchhausen T, Krieger M. Identification of the molecular target of small molecule inhibitors of HDL receptor SR-BI activity. Biochemistry. 2008;47:460-472.
28. Vedhachalam C, Narayanaswami V, Neto N, Forte TM, Phillips MC, Lund-Katz S, Bielicki JK. The C-terminal lipid-binding domain of apo-lipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins. Biochemistry. 2007;46:2583-2593.
29. Lang I, Schweizer A, Hiden U, Ghaffari-Tabrizi N, Hagendorfer G, Bilban M, Pabst MA, Korgun ET, Dohr G, Desoye G. Human fetal placental endothelial cells have a mature arterial and a juvenile venous phenotype with adipogenic and osteogenic differentiation potential. Differentiation. 2008;76:1031-1043.
30. Oldfield S, Lowry C, Ruddick J, Lightman S. ABCG4: a novel human white family ABC-transporter expressed in the brain and eye. Biochim Biophys Acta. 2002;1591:175-179.
31. Lutjohann D, Bjorkhem I, Locatelli S, Dame C, Schmolling J, von Bergmann K, Fahnenstich H. Cholesterol dynamics in the foetal and neonatal brain as reflected by circulatory levels of 24S-hydroxycholes-terol. Acta Paediatr. 2001;90:652-657.
32. Wassif CA, Yu J, Cui J, Porter FD, Javitt NB. 27-Hydroxylation of 7 and 8 dehydrocholesterol in Smith-Lemli-Opitz syndrome: a novel metabolic pathway. Steroids. 2003;68:497-502.
33. Bjorkhem I, Starck L, Andersson U, Lutjohann D, von Bahr S, Pikuleva I, Babiker A, Diczfalusy U. Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S and 27 hydroxycholesterol. J Lipid Res. 2001;42:366-371.
34. Albrecht C, Soumian S, Tetlow N, Patel P, Sullivan MH, Lakasing L, Nicolaides K, Williamson C. Placental ABCA1 expression is reduced in primary antiphospholipid syndrome compared to preeclampsia and controls. Placenta. 2007;28:701-708.
35. Christiansen-Weber TA, Voland JR, Wu Y, Ngo K, Roland BL, Nguyen S, Peterson PA, Fung-Leung WP. Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency. Am J Pathol. 2000;157:1017-1029.
36. Panzenboeck U, Balazs Z, Sovic A, Hrzenjak A, Levak-Frank S, Win-tersperger A, Malle E, Sattler W. ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells. J Biol Chem. 2002;277:42781-42789.
37. Panzenboeck U, Kratzer I, Sovic A, Wintersperger A, Bernhart E, Hammer A, Malle E, Sattler W. Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cells. Int J Biochem Cell Biol. 2006;38:1314-1329.
38. Fielding PE, Nagao K, Hakamata H, Chimini G, Fielding CJ. A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1. Biochemistry. 2000;39:14113-14120.
39. O'Connell BJ, Denis M, Genest J. Cellular physiology of cholesterol efflux in vascular endothelial cells. Circulation. 2004;110:2881-2888.
40. Jessup W, Gelissen IC, Gaus K, Kritharides L. Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Curr Opin Lipidol. 2006;17:247-257.
41. Gillotte-Taylor K, Nickel M, Johnson WJ, Francone OL, Holvoet P, Lund-Katz S, Rothblat GH, Phillips MC. Effects of enrichment of fibro-blasts with unesterified cholesterol on the efflux of cellular lipids to apolipoprotein A-I. J Biol Chem. 2002;277:11811-11820.
42. Lorenzi I, von Eckardstein A, Radosavljevic S, Rohrer L. Lipidation of apolipoprotein A-I by ATP-binding cassette transporter (ABC) A1 generates an interaction partner for ABCG1 but not for scavenger receptor BI. Biochim Biophys Acta. 2008;1781:306-313.
43. Solca C, Pandit B, Yu H, Tint GS, Patel SB. Loss of apolipoprotein E exacerbates the neonatal lethality of the Smith-Lemli-Opitz syndrome mouse. Mol Genet Metab. 2007;91:7-14.
44. Rindler MJ, Traber MG, Esterman AL, Bersinger NA, Dancis J. Synthesis and secretion of apolipoprotein E by human placenta and choriocar-cinoma cell lines. Placenta. 1991;12:615-624.
45. Cavelier C, Rohrer L, von Eckardstein A. ATP-binding cassette transporter A1 modulates apolipoprotein A-I transcytosis through aortic en-dothelial cells. Circ Res. 2006;99:1060-1066.